Cotización Abattis Bioceuticals - ATT | ADVFN

US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

Inicio
Invertir
Acciones
Canadá
CSE
Abattis Bioceuticals Corp (ATT) Cotización

Abattis Bioceuticals Corp (ATT)

0.08

0.00

(0.00%)

Cerrado 30 Diciembre 3:00PM

Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Último Precio

0.08

Postura de Compra

0.04

Postura de Venta

10.00

Volume Operado de la Acción

-

0.00 Rango del Día 0.00

0.08 Rango de 52 semanas 0.08

Precio Anterior

0.08

Precio de Apertura

-

Hora

Última hora de negociación

Volumen promedio (3 m)

-

Volumen financiero

-

Precio Promedio Ponderado

-

Abattis Provides Update on Trading Halt and Corporate Developments

VANCOUVER, British Columbia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) announces the following updates on recent...

Abattis Completes Year End Audit and Provides Corporate Update

VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) announces the filing of its annual financial...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0.08	0.08	0.08	0	0	CS
4	0	0	0.08	0.08	0.08	0	0	CS
12	0	0	0.08	0.08	0.08	0	0	CS
26	0	0	0.08	0.08	0.08	0	0	CS
52	0	0	0.08	0.08	0.08	0	0	CS
156	0	0	0.08	0.08	0.08	0	0	CS
260	0	0	0.08	0.08	0.08	0	0	CS

ATT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Abattis Bioceuticals?

El precio actual de las acciones de Abattis Bioceuticals es $ 0.08

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Abattis Bioceuticals?

Abattis Bioceuticals ha negociado en un rango de $ 0.08 a $ 0.08 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
ENRTEnertopia Corp	$ 0.015 (200.00%)	48.34k
XCXAMP Alternative Medical Products Inc	$ 0.025 (150.00%)	13k
BLSTBlast Resources Inc	$ 0.14 (133.33%)	1,000
VEJI.XVeji Holdings Inc	$ 0.18 (125.00%)	2k
TAITalmora Diamond Inc	$ 0.065 (116.67%)	96k
MYCOMydecine Innovations Group Inc	$ 0.005 (-50.00%)	943.05k
FFNT4Front Ventures Corp	$ 0.015 (-50.00%)	213.48k
EOMEco Oro Minerals Corp	$ 0.005 (-50.00%)	38k
RVVRevive Therapeutics Ltd	$ 0.005 (-50.00%)	1.96M
TONETriple One Metals Inc	$ 0.005 (-50.00%)	19k
QIMCQuebec Innovative Materials Corp	$ 0.08 (0.00%)	3.36M
NXU.XNexco Resources Inc	$ 0.005 (0.00%)	2.63M
PLUGEnergy Plug Technologies Corp	$ 0.14 (27.27%)	2.57M
RVVRevive Therapeutics Ltd	$ 0.005 (-50.00%)	1.96M
PMEDPredictmedix Al Inc	$ 0.015 (50.00%)	1.72M

Pickthepenny

Pickthepenny 5 años hace

This is a good possibility here. Looks like this may be something good to dip into

Alaska33

Alaska33 6 años hace

HIPH
Check it out...another runner this week!

KOLBYDOG

KOLBYDOG 6 años hace

ATT I'll take .215. Great late run, hopefully continues Tuesday.

KOLBYDOG

KOLBYDOG 6 años hace

I feel .25 end of day.

KOLBYDOG

KOLBYDOG 6 años hace

ATT Have my fingers crossed, believe this to be a big one.

MasterBidder

MasterBidder 6 años hace

Womp womp booooo

KOLBYDOG

KOLBYDOG 6 años hace

KOLBYDOG

KOLBYDOG 7 años hace

NEWS

VANCOUVER, British Columbia, February 27, 2018 /PRNewswire/ --

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT) (ATT.CN) (ATTBF) is pleased to announce that it has entered into a definitive agreement (the "Definitive Agreement") to acquire (the "Acquisition") a 90% ownership interest in Gabriola Green Farms Inc. ("Gabriola").

Gabriola is a privately held British Columbia company that has applied for a license to produce (an "LP") under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") on Gabriola Island, one of the gulf islands located in the Strait of Georgia off the coast of British Columbia. Gabriola Island has a consistent temperature and humidity level, which makes it well suited to greenhouse growing.

"This is one of the most significant steps our Company has taken towards becoming a full service cannabis company," stated Rob Abenante, Abattis President and CEO. "After successfully obtaining a license through Gabriola, we intend to not only cultivate marijuana, but more importantly sell extracted cannabis products, which will complete our full downstream service offerings."

The Definitive Agreement comes following a series of rapid acquisitions, capital raises, investments and joint-ventures for the Company, which include the acquisition of a cash flowing vaporizer company, investment into a cutting-edge Blockchain technology and cryptocurrency and several collaborations with respected organizations, including the University of British Columbia.

Rhodeo

Rhodeo 7 años hace

everyone uses the american version of this board ATTBF

Already made it

Already made it 7 años hace

The demand these extractions far exceeds the current supply. And will always be for the next 5-10 yrs IMO

All MJ companies will profit.. as Donald trump says “Huuuuuige”

snidclothing

snidclothing 7 años hace

Where is everyone? How does att add up amongst the "extractors"?

Anty_Jr

Anty_Jr 7 años hace

News - Abattis Announces Expansion of Northern Vine Dealer’s License
https://finance.yahoo.com/news/abattis-announces-expansion-northern-vine-120000894.html

Abattis Bioceuticals

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones